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Summary:  
 The cell is comprised of integrated multi-level protein networks or systems. The 
ubiquitin, protein homeostasis and membrane trafficking systems are highly integrated. 
Here we look at the influence of reversible ubiquitylation on membrane trafficking and 
organelle dynamics. We review the regulation of endocytic sorting, selective 
autophagy and the secretory pathway by ubiquitin signals, with a particular focus on 
detailing the contribution of deubiquitylating enzymes. 
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Abbreviations: 
 
ALG2; Asparagine-Linked Glycosylation Protein 2 Homolog 
AMSH; associated molecule with the SH3-domain of STAM 
ATG; autophagy related gene/protein  
BTB; Broad-Complex, Tramtrack and Bric a brac domain 
Cbl; Casitas B-Lineage Lymphoma Proto-Oncogene 
ciM6PR; cation-independent mannose 6-phosphate receptor 
CFTR; cystic fibrosis transmembrane conductance regulator  
CRL; Cullin-RING ubiquitin ligase 
DUB; deubiquitylase or deubiquitinase 
E1; ubiquitin-activating enzyme 
E2; ubiquitin-conjugating enzyme 
E3; ubiquitin ligase 
ELDR; Endo-lysosomal damage response  
EGFR; Epidermal Growth Factor Receptor  
EPS15; Epidermal Growth Factor Receptor Pathway Substrate 15 
ER; endoplasmic reticulum 
ERAD; ER-associated degradation  
ESCRT; Endosomal Sorting Complex Required for Transport 
Fz; Frizzled  
GABARAP; GABA(A) receptor-associated protein 
GFP; Green fluorescent protein 
GPCR; G protein–linked receptors 
HACE1; HECT Domain And Ankyrin Repeat Containing E3 Ubiquitin Protein Ligase 1 
HECT; Homologous to the E6-AP Carboxyl Terminus 
HRS (HGS); Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate 
IDOL; Inducible Degrader Of The LDL-Receptor 
ILVs intra-lumenal vesicles 
LC3; Light Chain 3 
LDLR; Low-Density Lipoprotein (LDL) receptor 
LRP6; LDL Receptor Related Protein 6 
MAPS; Misfolding Associated Protein Secretion 
MIC-CAP; Microcephaly-Capillary Malformation Syndrome 
MIT; Microtubule interacting and transport domain 
MVB; multi-vesicular body  
MYLIP; Myosin Regulatory Light Chain Interacting Protein 
NEDD4; Neural Precursor Cell Expressed, Developmentally Down-Regulated 4 
PD; Parkinson’s Disease  
PDGFR; Platelet-derived growth factor receptor 
PEF1; Penta-EF-Hand Domain Containing 1 
PINK1; PTEN Induced Putative Kinase 1 
PLAA; Phospholipase A2 Activating Protein 
PTP1B; Protein Tyrosine Phosphatase, Non-Receptor Type 1 
PTEN; Phosphatase And Tensin Homolog 
pUb; Ubiquitin phosphorylated on Ser65 
RING; really interesting new gene 
RNF26; Ring finger Protein 26 
ROS; Reactive oxygen species 
RTK; Receptor tyrosine kinase 
Smo; Smoothened  
SNARE; Soluble N-ethylmaleimide attachment protein receptor 
SNCA; α-synuclein 
SNX1; Sorting nexin 1 
SPOPL; Speckle Type BTB/POZ Protein Like 
SQSTM1; Sequestosome 1 
STAM; Signal Transducing Adaptor Molecule 
TCRα; T-cell receptor-α  
TGN; trans-Golgi Network 
TOLLIP; Toll Interacting Protein 
TRIM27; Tripartite Motif Containing 27 
Ubl; Ubiquitin-like domain 
USP; Ubiquitin specific protease 
VCIP135; Valosin Containing Protein Interacting Protein 1 
VEGFR; Vascular Endothelial Growth Factor Receptor 
VHL; von-Hippel Lindau  
VPS; vacuolar protein sorting 
VSV G; Vesicular stomatitis virus glycoprotein 
WASH; WASH and scar homolog 
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Introduction 
 The complement of expressed proteins provide the building blocks for an 
integrated set of systems that combine to produce the overall cell behaviour. The 
ubiquitin system constitutes greater than 1.5% of cellular protein. It overlaps with the 
proteostasis system but also with the cell signalling system by generating a complex 
signalling code on 1000’s of substrate proteins [1-3]. The spectrum of ubiquitylated 
proteins in a cell is determined by the net activity of ubiquitin conjugation cascades 
(involving E1s, E2s and E3s), which principally attach ubiquitin molecules to lysine 
residues, balanced by the opposing action of the deubiquitylating enzymes (DUBs), 
which hydrolyse this isopeptide bond. The seven internal lysines of ubiquitin allow for 
the formation of topologically distinct ubiquitin isopeptide chain types. These, together 
with a minor fraction of linear ubiquitin chains and a large fraction of mono-
ubiquitylation sites may be recognised by multiple types of reader proteins that contain 
ubiquitin binding domains that effectively translate the ubiquitin code [4, 5]. Some E2s, 
DUBs and readers display exquisite selectivity for particular ubiquitin chain linkage 
types, whilst others  show little discrimination. The length of a ubiquitin chain is also 
an important parameter that can determine avidity for lower affinity binders. The cell 
membrane traffic system controls protein turnover through endocytosis and autophagy, 
but more fundamentally maintains compartmental organisation in the face of large 
scale membrane flux. Here, we will discuss the integration of the ubiquitin and 
membrane trafficking systems.  
 Sub-cellular compartmentalisation results from the differential trafficking 
patterns of membrane components. From the point of view of ubiquitin conjugating 
and deubiquitylating enzymes, it provides a means to confer specificity by restricting 
the palette of available substrates. Thus, understanding of the ubiquitin system may 
require localisation data for all components. To date, systematic sub-cellular 
localisation has been reported for the majority of DUBs and for the fraction of RING E3 
ligases possessing a trans-membrane domain [6-9]. In this review we will explore the 
impact of reversible ubiquitylation on membrane trafficking and organelle dynamics. 
  
 
Ubiquitin as a sorting signal. 
 The distribution of membrane proteins is largely governed through a balance of 
active sorting and retention signals, which governs their inclusion into vesicular or 
tubular transport intermediates [10]. For the most part their flow is constitutive, 
determined by intrinsic sequence mediated signals (e.g. KDEL for ER retention, NPXY 
for endocytosis of LDL receptor). Cells also reconfigure the sub-cellular distribution of 
proteins in response to prevailing conditions. In many cases, ligand occupancy of 
receptors is coupled to their redistribution, which is accomplished through the 
generation of sorting signals by post-translational modification. Although ubiquitylation 
can serve as a supplementary plasma membrane internalisation signal, for numerous 
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receptors its most critical function resides at the sorting endosome. Here, it promotes 
receptor incorporation into intra-lumenal vesicles (ILVs) of the multi-vesicular body 
(MVB) which commits cargo for lysosomal degradation [11]. 
 Early work in the 1990’s identified ubiquitylation of a number of plasma 
membrane proteins but its significance for membrane trafficking only became clear 
after pioneering studies in yeast [12-14]. Shortly thereafter, studies of C. elegans vulval 
development led to the identification of SLI-1, a homologue of the ubiquitin E3-ligase 
c-Cbl, as a negative regulator of signaling downstream of the LET-23 receptor tyrosine 
kinase (RTK) [15]. Extension of these results to human cells quickly followed, with the 
observation that EGFR recruits c-Cbl to endosomes leading to Epidermal Growth Factor 
Receptor (EGFR) ubiquitylation and receptor down-regulation through lysosomal 
sorting [16]. Mass spectrometry studies suggest that EGFR is ubiquitylated at multiple 
sites, with Lys63-linked chains highly represented and necessary for sorting [17, 18]. A 
prominent role for Lys63-linked ubiquitin chains in the endosomal pathway is also 
evident in yeast [19]. c-Cbl mediated ubiquitylation was established as a widely used 
sorting signal that promotes lysosomal sorting of multiple activated RTKs (e.g. EGFR, c-
MET, PDGFR) [20]. There are exceptions, for example ITCH was identified as the 
major E3-ligase dictating degradation of the EGFR family member, ERBB4 [21]. Other 
classes of receptors such as chronically activated G-protein coupled receptors (GPCRs) 
use ubiquitylation for lysosomal down-regulation, but the cognate E3s are likely more 
variable (e.g. NEDD4 ubiquitylates ß2-adrenergic receptor [22]). Under conditions of 
excess cholesterol, LDL receptors are down-regulated following the induced expression 
of the E3-ligase MYLIP/IDOL [23, 24]. 
 
Ubiquitin and receptor internalisation 
 Ubiquitylation is one of several potential internalisation signals following 
receptor activation that allows coupling to adaptor proteins for both clathrin-dependent 
and independent internalisation pathways [25]. In the case of EGFR, a ubiquitin-
dependent non-clathrin pathway can be favoured under conditions of full receptor 
activation [26]. A recent siRNA screen identified up to fifteen DUBs influencing EGFR 
receptor turnover. Prominent positive regulators include USP6 and USP9X [27] (Figure 
1). Of these, USP6 showed the most pronounced plasma membrane localisation in a 
systematic survey of GFP-DUB localisation [9]. In a separate whole genome siRNA 
screen USP6 was found to activate Wnt signaling by deubiquitylating Frizzled 
receptors and increasing their plasma membrane expression [28]. 
 A number of accessory proteins associated with receptor internalisation have 
ubiquitin binding domains, but are themselves mono-ubiquitylated in an EGF-
dependent manner (EPS15, EPS15R and Epsin) [29]. USP9X depletion retards EGFR 
internalisation at low doses of EGF, when only the clathrin dependent pathway is 
operative, and little if any receptor is ubiquitylated. Savio and colleagues suggest that, 
the relevant USP9X substrate is in fact the monoubiquitylated protein EPS15, but the 
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mechanistic details of how this might influence internalisation are currently unclear 
[27]. Studies in yeast suggest that deubiquitylation of the EPS15 homologue, Ede1 by 
Ubp2 and Ubp7, influences the rate of clathrin coated vesicle formation [30]. In 
addition to its role in governing receptor internalisation, USP9X also plays a positive 
role in directing lysosomal trafficking from the sorting endosome [27]. However it does 
not directly influence the ubiquitylation status of the receptor itself, once again 
suggesting an indirect mechanism. Candidate substrates include the E3 ligase ITCH that 
associates with endosomes [31], or in fact an endosomal fraction of EPS15, which is 
ubiquitylated by the SPOPL/Cullin-3 ubiquitin ligase [32]. One further siRNA screen 
across the DUB family identified Cezanne as a negative regulator of EGFR down-
regulation [33]. 
  
Regulation of endosomal sorting by DUBs 
 Endosomal sorting is accomplished through capture of ubiquitylated cargo at 
the endosome membrane by components of the Endosomal Sorting Complex Required 
for Transport (ESCRT) machinery [34, 35]. This machinery promotes lumenal budding 
of cargo containing ILVs from the limiting membrane [36] and terminates growth factor 
receptor signaling by sequestration from the cytosol. It is classically divided into four 
sub-complexes, ESCRTs 0,I,II and III. Two DUBs, USP8 (also known as UBPY) and 
AMSH (STAMBP) are integrated within this complex protein network. The ESCRT-0 
complex, comprising HRS (HGS) and STAM, presents the first point of engagement of 
ubiquitylated receptors through multiple ubiquitin binding domains [34]. Both DUBs 
engage with ESCRT-0 by competing for a shared binding site on STAM. They also both 
contain N-terminal MIT domains, which bind to overlapping spectra of multiple 
ESCRT-III proteins [37-39]. USP8 and AMSH belong to different sub-families of DUBs; 
ubiquitin specific proteases and the metalloprotease JAMM family respectively. AMSH 
has exquisite specificity for Lys63-linked ubiquitin chains, whilst USP8 is non-selective 
[40-44]. In vitro, both are activated through association with STAM, which binds to 
ubiquitin and decreases the Km [41, 45, 46]. 
 As ubiquitin is a reversible post-translational modification, a simple model 
posits that receptor fate at the endosome will be governed by competing ubiquitin-
conjugating and deubiquitylating activities [47]. The Lys63-linkage specific DUB, 
AMSH, conforms to this model [41]. Its depletion leads to enhanced degradation 
kinetics of acutely-activated EGFR and its ligand [27, 33, 40, 48]. Fusion of AMSH to 
the C-terminus of EGFR blocks receptor degradation [18]. AMSH is also recruited to 
GAP junction plaque sites and negatively regulates the turnover of the GAP junction 
protein Connexin 43 [49]. Note that the exquisite selectivity of AMSH for Lys63-linked 
ubiquitin will only allow for editing of ubiquitin chains, and that it cannot remove the 
proximal ubiquitin directly attached to receptors. Mutations in AMSH lead to 
Microcephaly-Capillary Malformation Syndrome (MIC-CAP) [50]. These generally 
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cluster in its MIT domain, but a catalytically inactivating mutation (T313I) has also 
been characterised [51].  
 USP2 has also been shown to localise to endosomes and negatively regulate 
EGFR down-regulation [52]. This enzyme will cleave all ubiquitin linkage types 
including the proximal ubiquitin. Loss of either protein provided a similar impact on 
EGFR degradation in the family wide DUB screen of Savio et al. [27]. USP2 interacts 
with and stabilises the sterol-regulated E3-ligase IDOL but also rescues LDLR from 
lysosomal degradation, recalling the example of USP7 described in detail below [53]. 
This principle of negative regulation of lysosomal sorting has been extended to many 
ubiquitylated receptors and channels and to other DUB family members. Examples 
include, the stabilisation of cystic fibrosis transmembrane conductance regulator 
(CFTR) by USP10 [54] and glutamate receptors in both nematode and mammalian 
model systems by USP46 [55, 56].  
 The effects of USP8 depletion are profound and widespread, leading to a major 
disruption of endosomal organisation. In distinction to AMSH, USP8 depletion 
predominantly impairs RTK degradation, but in addition blocks the retromer-dependent 
retrieval of the cation-independent mannose 6-phosphate receptor (ciM6PR) to the 
Golgi apparatus and the plasma membrane recycling of the VEGFR2, Frizzled (Fz) and 
Smoothened (Smo) [27, 45, 57-61]. One major consequence of USP8 depletion is the 
loss of both ESCRT-0 components, HRS and STAM, which are turned over in a 
proteasome-dependent manner [45, 62, 63]. Despite binding to the same site on STAM 
and being expressed at similar levels [5], AMSH cannot compensate for USP8 loss 
owing to its restricted ubiquitin chain specificity [64]. In addition, USP8 governs the 
global flux of cellular ubiquitin; its depletion drains the nucleus of ubiquitin by 
accumulation on endosomes [45, 60]. Note that the pleiotropic effects of USP8 make 
the observed phenotypes very sensitive to the efficiency of depletion in siRNA 
experiments, as explicitly addressed by Mizuno et al. [65]. Certain scenarios e.g. sub-
optimal depletion or particular cell types, reveal negative regulation of lysosomal 
trafficking by USP8 [66, 67] (Figure 1). Over-expression of USP8 also leads to 
enhanced recycling of the epithelial Na+ channel [68]. Activating mutations in USP8 
have been linked to Cushings Disease, which is caused by corticotroph adenomas of 
the pituitary [69, 70]. One suggestion is that this may reflect increased levels of EGFR 
through enhanced recycling to the plasma membrane.  
 The effect of USP8 on the retromer pathway may be linked to it’s control of HRS 
stability. HRS has been suggested to interact with the core retromer components SNX1 
and VPS35 and to influence this pathway [71]. The retromer-dependent pathway 
requires the participation of F-actin which is recruited by the WASH complex. Activity 
of WASH is positively regulated by ubiquitylation, mediated by an E3 ligase complex 
of TRIM27 and MAGE-L2 [72]. Hao et al. have reported that USP7 incorporates into 
this complex through interactions with both components and localises to endosomes 
(Figure 1) in addition to the nucleus where it has previously established roles [73]. 
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USP7 has opposing activities in the context of the retromer pathway; it stabilises the 
WASH E3-ligase TRIM27 by opposing its auto-ubiquitylation, but it also 
deubiquitylates WASH itself. It is proposed that USP7 is used to buffer WASH 
ubiquitylation to maintain optimal endosomal activity and F-actin levels. Interestingly 
heterozygous deletion or mutation of USP7 leads to mental impairments that resemble 
Schaaf-Yang syndrome which is associated with MAGE-L2 mutations [73]. 
 There is an emerging appreciation that distinct organelles can influence each 
other at sites of direct contact. For example the ER localised phosphatase, PTP1B, can 
dephosphorylate the EGF receptor on endosomes [74]. The closely related DUBs, 
USP20 and USP33, deubiquitylate activated ß-adrenergic receptors as well as the 
adaptor/signaling protein ß-arrestin (USP33), to favour recycling from endosomes, 
despite largely being associated with the secretory pathway [75-77]. In a further 
intriguing model, the ER-restricted E3-ligase RNF26 is proposed to ubiquitylate 
SQSTM1/p62 which then links to ubiquitin receptors on specific organelles such as 
endosomes, e.g. EPS15, TOLLIP to retain them on the ER surface and confine them to 
perinuclear regions (Figure 2) [78]. How this relates to an existing model suggesting 
that SQSTM1 links cargo to the (-) end directed microtubule motor protein, dynein, is 
unclear [79]. USP15, which has also been identified as a binding partner of the ER-
associated E3, RNF26, reverses this capture by deubiquitylating SQSTM1, increasing 
endosome mobility and global distribution [78]. 
 
Ubiquitylation a key mediator of selective autophagy 
 Early studies of autophagy emphasised its role as an adaptive response to amino 
acid deprivation, through the indiscriminate breakdown of cytosolic components. It is 
now clear that many modes of selective autophagy exist and that, in most, but not all 
cases, accumulation of ubiquitin provides the means to recruit adaptor proteins, which 
bridge to LC3/GABARAP-coated phagophore membranes [80]. It seems likely that 
multiple widely distributed ubiquitin binding sites on the target body will favour 
coupling to autophagosomes rather than proteasomes using the co-operativity between 
multiple weak binding interactions of adaptors for both ubiquitin and LC3. In most 
cases it would seem that a relatively delocalised coating with ubiquitin is more critical 
than ubiquitylation of specific protein substrates. DUBs may act to limit this distress 
signal or alternatively act to stabilise core components of the autophagy pathway. For 
example USP9X and USP10 have been proposed to regulate the stability of VPS34 
complex components [81, 82]. Autophagosomes then fuse with lysosomes to generate 
autolysosomes. Autophagic flux is therefore reliant on appropriate organisation of the 
endolysosomal system.  
 Several studies have highlighted a role for USP8 in various aspects of 
autophagy, mirroring its complex contribution to endosomal functions (see above). A 
screen in the Drosophila larval fat body for DUBs influencing autophagy identified 
USP12 and USP8 as regulators of autophagic flux. In larval fat body cells depleted of 
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USP8 autophagic degradation is blocked, presumably owing to the associated 
lysosomal defects. In contrast, when the authors turned to HeLa cells they found that 
depletion of USP8 increased the number of intracellular punctae decorated with the 
autophagic marker GFP-LC3, with a proportionate increase in the autophagic flux [83]. 
The accumulation of α-synuclein (SNCA) in neuronal inclusions known as Lewy bodies 
is a hallmark of Parkinson’s Disease (PD). Recent data suggest that USP8 may 
negatively regulate α-synuclein degradation by removal of Lys63 ubiquitin chains. At 
this point it is not clear if this represents a deflection from the autophagic pathway or 
from capture of soluble protein into MVBs. Most strikingly a rough eye phenotype in 
Drosophila, induced by α-synuclein expression can be reversed by USP8 depletion  
[84].  
 
Mitophagy 
 Defective mitochondria can depolarise and accumulate the damage sensor 
PTEN-induced putative kinase 1 (PINK1) on their surface [85]. This enables recruitment 
of the E3-ligase Parkin to the surface of mitochondria. Loss of function mutations in 
PINK1 and Parkin lead to PD. Full activation of Parkin requires both its own 
phosphorylation by PINK1 and phosphorylation of ubiquitin on Ser65 (pUb). PINK1-
generated pUb acts as a Parkin receptor on mitochondria and elicits a conformational 
change which is stabilised by PINK-dependent phosphorylation of an internal Ubl 
domain [86-88] (Figure 3). This leads to clearance of mitochondria via the autophagy 
pathway utilising specific adaptor proteins, optineurin and NDP52 [85, 89-91]. 
 USP30 is the major mitochondrial DUB, facing the cytosol and anchored to the 
outer membrane through a trans-membrane sequence [92]. It is optimally placed to 
reverse the Parkin-dependent ubiquitylation of multiple mitochondrial surface proteins 
and thereby limit mitophagy [93, 94]. Mitochondrial damage stimulates Parkin to 
generate Lys6, Lys11 and Lys 63-linked polyubiquitin chains, whilst USP30 
preferentially disassembles the Lys6 and Lys11-linked multimers. However, USP30 is 
less active towards pUB chains, which are likely to be concentrated at sites of PINK1 
activity [95-98]. We suspect these chain specificities to have functional significance. 
For example USP30 may be less effective in opposing early stages of initiating the 
ubiquitin signal where pUb generated by PINK1 may be most important. Rather, it 
might limit its subsequent amplification by Parkin, which is recruited to pUb modified 
mitochondrial proteins [86]. 
 USP30 over-expression impairs Parkin recruitment to depolarised mitochondria 
and blocks mitophagy [85, 99]. Conversely, its depletion enhances mitophagic flux in 
cultured neurons and epithelial cells [85, 99]. In PINK1/Parkin defective, or paraquat 
treated fly models of PD, depletion of USP30 can restore motor function and dopamine 
levels [85]. Reversal of Parkin ubiquitylation at mitochondria primarily reflects the 
specific localisation of USP30, since targeting other USP family members to 
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mitochondria can fulfill the same function and directing USP30 to peroxisomes 
protects them from pexophagy [97]. 
 Similar claims have been made for USP15, which is more widely distributed 
throughout the cytoplasm and associated with diverse cellular functions. Over-
expression of USP15 reduced ubiquitin accumulation on mitochondria, whilst 
depletion rescued mitophagy defects in PD patient derived fibroblasts. Concomitant 
depletion of a proposed Drosophila USP15 orthologue mitigated the effects of Parkin 
knock-down by siRNA [100]. It is presently unclear, how direct the effect of USP15 
may be. Cornelissen et al. first focused on USP15 after identifying it as co-
immunoprecipitating with His6-FLAG-tagged Parkin, but other extensive Parkin 
interactome studies have not found a similar interaction [100-102]. A short form of 
USP35 (s-USP35) has also been localised to mitochondria and is suggested to regulate 
mitophagy [99]. However note that this form of the enzyme lacks a catalytic domain. 
USP8 is proposed to have a non-endosomal function in controlling Parkin auto-
ubiquitylation with predominantly Lys6-linked chains. By virtue of this activity, Parkin 
recruitment to acutely depolarised mitochondria is accelerated and mitophagy 
proceeds more efficiently [103].  
 
Endo-lysosomal damage response (ELDR). 
 Endosomal compartments may get damaged by endogenous factors including 
ROS and neurotoxic aggregates, in the course of pathogen entry and experimentally, 
through the application of various transfection reagents [104]. This leads to 
ubiquitylation and recruitment of the autophagic machinery via specific adaptor 
molecules such as Atg16L1 [105]. Papadopoulos et al. described a role for the AAA-
ATPase p97 in the efficient clearance of damaged endosomal compartments by 
selective autophagy, following the application of a lysosomotropic agent. Three p97 
interacting proteins, UBXD1, PLAA and the DUB YOD1/OTUD2, were also required 
for the clearance of damaged lysosomes. A positive requirement for a DUB in 
autophagic clearance is unexpected. They suggest that a sub-set of Lys63 ubiquitin 
chain decorated endosomes also accumulate Lys48-linked chains which need to be 
removed by YOD1 to allow envelopment by LC3 containing phagophores [106]. In 
vitro, YOD1 discriminates between these chain types, although Lys 27,29 and 33 
chains are preferred substrates [44].    
 
Ubiquitin and the secretory pathway: 
  The major function of ubiquitin, heretofore associated with the secretory 
pathway is mediation of the ER-associated degradation (ERAD) pathway, which has 
been extensively reviewed elsewhere [107].  A role of non-specified DUB activity has 
been proposed in sharpening the discrimination of triaged ERAD substrates, much as 
proposed for both endosomal and proteasome associated DUBs [108]. In preceding 
studies the ER localised USP19 was shown to rescue the ERAD substrates cystic fibrosis 
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transmembrane conductance regulator (CFTR)ΔF508 and T‐cell receptor‐α (TCRα) from 
proteasomal degradation [109]. Several DUBs associate with the retro-translocation-
driving ATPase p97 (e.g. YOD1, ATXN3, USP13), some of which can positively 
regulate the ERAD pathway [7, 110-112].  
 Some DUBs show clear association with organelles of the secretory pathway, 
yet distinct roles in membrane trafficking have not been reported. One exception is the 
isoform of USP19, which contains a trans-membrane anchor that exclusively targets it 
to the ER [9, 109].  Recent work has associated it with an unconventional secretion 
pathway that becomes important under conditions of proteasome depletion or 
disfunction (Misfolding Associated Protein Secretion, MAPS). The catalytic domain of 
USP19 is proposed to capture mis-folded protein (including α-synuclein) at the surface 
of the ER and facilitate their transfer into vesicular structures that contain late 
endosomal markers (e.g. rab9), but are distinct from exosome carriers. This property of 
USP19 requires both ER localisation and catalytic activity. The resultant carrier vesicles 
then secrete proteins after fusion with the plasma membrane [113]. A further 
“chaperone like” activity of USP19 has also recently been proposed. Folding of the 
Wnt signaling co-receptor LRP6 is promoted by ubiquitylation of a specific cytosol 
facing lysine which promotes its retention in the ER. Exit from the ER of folded protein 
is then enabled by USP19 mediated deubiquitylation [114] (Figure 2). 
 Other functions of ubiquitin associated with vesicle trafficking and 
compartmental identity are beginning to emerge. Properly folded secretory proteins are 
packaged into COPII vesicles for transport from the ER to the cis-Golgi. Early studies in 
yeast suggested that a complex of Bre5 and the DUB Ubp3 regulate this process, 
possibly by sustaining the levels of the COPII coat component Sec23p [115]. Some 
secreted proteins such as collagen and fibronectin are too large to be included in a 
standard size vesicle, presenting a long standing conundrum to the field [116]. Jin et al. 
have shown that mono-ubiquitylation of the COPII component Sec31p permits 
expansion of vesicle size and increased secretion of collagen. The relevant E3 ligase 
has been identified as a cullin-RING ubiquitin ligase (CRL) complex incorporating the 
BTB protein KLHL12 as a recognition module in conjuction with two penta-EF-hand 
calcium binding proteins PEF1 and ALG2 which couple a transient rise in Ca2+ to a 
more sustained ubiquitin signal on Sec31p [117, 118]. Secretion of another large 
protein fibronectin is controlled by the cytosolic CRL incorporating von-Hippel Lindau 
(VHL) adaptor sub-unit [119]. 
 The related DUBs, USP20 and USP33 are also present on the ER. They have 
both been linked to the maintenance of activity of the ER associated type 2 
iodothyronine deiodinase that activates thyroxine [120]. Both also interact with VHL  
but only USP20 appears to influence its stability [121]. USP33 also resides on COPII 
vesicles and on the Golgi Apparatus. Its distribution can be shifted according to which 
splice variant is expressed, such that variant 3 selectively accumulates on the Golgi 
apparatus [77]. 
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 During mitosis the Golgi complex fragments in order to achieve an equal 
distribution of organelle between progeny cells. Reassembly requires SNARE proteins, 
in common with the majority of intracellular membrane fusion events [10]. A fraction 
of the Golgi t-SNARE, syntaxin 5 is monoubiquitylated by the E3-ligase HACE1 in early 
mitosis leading to a block in the interaction with its cognate v-SNARE Bet1 [122, 123]. 
It concomitantly increases interaction with the p97/p47 complex, which then promotes 
post-mitotic Golgi assembly following ubiquitin removal by its interacting DUB 
VCIP135 [123-126]. Temporal control is strengthened through phosphorylation-
dependent inactivation of VCIP135 early in mitosis and  reversal by phosphatase 
activity late in mitosis [126, 127].  
 Anterograde trafficking from the Trans-Golgi Network routes cargo to the 
plasma membrane or to the lysosome. Studies with mutant ubiquitin molecules suggest 
distinct roles for Lys33 and Lys63 chains in post-Golgi trafficking [128]. The CUL3-
KLHL20 E3-ligase promotes Lys33 chains on Coronin 7 which is then recruited by a 
Golgi-localised fraction of EPS15. This is proposed to promote F-actin assembly which 
in turn favours the budding of transport carriers destined for the plasma membrane (e.g. 
VSV G protein) or the endo/lysosomal pathway (e.g. ciM6PR) [128]. 
  
Concluding remarks 
 DUBs are most simply conceived as negative regulators of ubiquitin dependent 
processes. This holds true for their control of several ubiquitin mediated protein sorting 
events, where they may directly deubiquitylate cargo proteins. Similarly, we also 
expect more DUBs to be discovered that dampen signals for selective autophagy 
events, in addition to USP30. However, the preceding text also highlights positive roles 
for DUBs in more complex pathways, which might require cycles of ubiquitylation and 
deubiquitylation. Several generic reasons for this may be envisaged (i) ubiquitin chain 
editing to switch or harmonise a linkage type (ii) release from a ubiquitin receptor (iii) 
control of stability of cognate E3-ligases by opposing their auto-ubiquitylation (iv) 
control of stability of other accessory factors.  
 The current survey illustrates that a significant fraction of the ~100 DUB 
components of the ubiquitin system impact upon the cellular membrane trafficking 
system. However, several specific membrane trafficking events have been shown to be 
ubiquitin-dependent, without relevant DUB activities so far being characterised. Some 
DUBs show distinct sub-cellular distributions, without a clear understanding of their 
localised function. DUBs help shape the cellular architecture, but then use this 
foundation to influence further systems, such as cell signaling. For example, we have 
seen that USP30 can influence mitochondrial dynamics, we might further expect it to 
influence ubiquitin-dependent signaling systems associated with mitochondria. To 
progress our understanding of the ubiquitin system we will need to have an idea of its 
demographics (the abundance of each functional component [5]) as well as its 
geography (distribution and landscape). 
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Figure legends  
 
Figure 1: DUBs control trafficking through the endocytic pathway.  
Depicted  are those DUBs that have been shown to affect (a) the internalisation process 
of a variety of transmembrane proteins (e.g. EGFR), (b) endo-lysosomal sorting of cargo 
(e.g. EGFR) by the ESCRT-machinery, leading to lysosomal degradation and (c) 
retromer and WASH-dependent recycling of cargo proteins to the TGN (e.g. Mannose-
6-Phosphate receptor). Proposed substrates are shown in brackets. Note that USP8 has 
been proposed to positively and negatively regulate endolysosomal trafficking, possibly 
reflecting its dual role in deubiquitylating both the ESCRT-0 HRS/STAM complex and 
the EGFR itself. Dashed arrows show the path taken by cargo along the endocytic 
trafficking routes. Other DUBs implicated in endocytic trafficking of specific cargo, e.g. 
USP10 and USP46 are not shown.  
 
Figure 2: Deubiquitylase activities associated with endosplasmic reticulum associated 
vesicles.  
(a) The integral ER protein RNF26 is proposed to ubiquitylate SQSTM1/p62, which in 
turn functions to tether a variety of vesicles including endosomes via endosomal 
ubiquitin-binding adaptors, in the peri-nuclear area. USP15, which is a cytoplasmic 
protein is thought to release the vesicles by deubiquitylating SQSTM1.  
(b) The ER transmembrane protein USP19 has been suggested to act as a chaperone to 
promote the transfer of misfolded alpha-synuclein (SNCA) into the lumen of RAB9 
positive late endosomal vesicles, which subsequently exocytose their content by fusion 
with the plasma membrane via a non-canonical MAPS pathway.  
(c) USP19 engages in a number of quality control pathways, including ERAD (not 
shown) and the ubiquitin-dependent ER-exit of the palmitoylated and glycosylated 
LRP6 transmembrane protein via vesicular carriers. 
 
Figure 3: Selective autophagy is regulated by mutiple DUBs.  
(a) Mitophagy is triggered by the activation of PINK1 and Parkin leading to the 
accumulaton of Lys6,11 and 63-linked Ub chains, containing pUb, on the outer 
mitochondrial membrane. These promote the association of ubiquitin-binding adapter 
proteins that recruit LC3-decorated autophagic membranes. USP30 and USP15 have 
been shown to counteract this process by removing ubiquitin from Parkin substrates. 
USP8 has been proposed to remove inhibitory Lys6-linked ubiquitin chains from 
Parkin.  
(b) The endo-lysosomal damage response ensures the clearance of damaged lysosomes 
via autophagy. Lys63-linked chains are proposed to act as an enabling ubiquitin 
modification in this process and promote the recruitment of the autophagic machinery. 
In contrast, Lys48-linked chains associated with some of the damaged lysosomes need 
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to be removed by the DUB YOD1, a component of the Endo-Lysosomal Damage 
Response complex (ELDR).  
(c) Mis-folded alpha-synuclein aggregates have been shown to accumulate Lys63-
linked ubiquitin chains which promote its degradation within lysosomes. USP8 is 
proposed to remove these ubiquitin chains and interfere with the clearance of alpha-
synuclein aggregates. 
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